<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Breast cancer is the leading cause of death among women worldwide. The main limitations of conventional anti-cancer therapy, including breast cancer treatment, are side effects and the development of resistance to chemotherapeutics. Host defense peptides (HDPs) are bioactive compounds of innate immunity isolated from almost all living organisms, which exhibit wide range of biological activities. This review focuses on the anti-cancer effects of HDPs and their therapeutic potential against breast cancer. Numerous HDPs from different sources, including mammalian and amphibian origin, and their chemically modified analogues, exert the spectrum of anti-cancer activities. These effects include direct disruption of cancer cell membrane, induction of apoptosis, inhibition of angiogenesis and cancer cell proliferation, but also the modulation of anti-cancer immune response. Selected examples of HDPs of different origin and their anti-breast cancer capacities have been reviewed. Conclusively, due to their anti-cancer effects accompanied by substantial selectivity for cancer cells and low toxicity for normal cells, HDPs have been widely recognized as possible therapeutic agents.</p>
</abstract>

Breast cancer is the leading cause of death among women worldwide. The main limitations of conventional anti-cancer therapy, including breast cancer treatment, are side effects and the development of resistance to chemotherapeutics. Host defense peptides (HDPs) are bioactive compounds of innate immunity isolated from almost all living organisms, which exhibit wide range of biological activities. This review focuses on the anti-cancer effects of HDPs and their therapeutic potential against breast cancer. Numerous HDPs from different sources, including mammalian and amphibian origin, and their chemically modified analogues, exert the spectrum of anti-cancer activities. These effects include direct disruption of cancer cell membrane, induction of apoptosis, inhibition of angiogenesis and cancer cell proliferation, but also the modulation of anti-cancer immune response. Selected examples of HDPs of different origin and their anti-breast cancer capacities have been reviewed. Conclusively, due to their anti-cancer effects accompanied by substantial selectivity for cancer cells and low toxicity for normal cells, HDPs have been widely recognized as possible therapeutic agents.

Overview of Host Defense Peptides with Promising Anti-Breast Cancer Activity

University of Kragujevac, Faculty of Medical Sciences

Experimental and Applied Biomedical Research (EABR)

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"Overview of Host Defense Peptides with Promising Anti-Breast Cancer Activity"}

Breast cancer is the leading cause of death among women worldwide. The main limitations of conventional anti-cancer therapy, including breast cancer treatment,...

Overview of Host Defense Peptides with Promising Anti-Breast Cancer Activity

Publié en ligne: 14 oct. 2022

Pages: -

Reçu: 30 juin 2021

Accepté: 27 juil. 2021

DOI: https://doi.org/10.2478/sjecr-2021-0052

Mots clés
Breast cancer, host defense peptides, anti-cancer activity, cytotoxicity, therapy

© 2021 Sanja Zornic et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Overview of Host Defense Peptides with Promising Anti-Breast Cancer Activity

Publié en ligne: 14 oct. 2022

Pages: -

Reçu: 30 juin 2021

Accepté: 27 juil. 2021

DOI: https://doi.org/10.2478/sjecr-2021-0052

Mots clésBreast cancer, host defense peptides, anti-cancer activity, cytotoxicity, therapy

© 2021 Sanja Zornic et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mots clés
Breast cancer, host defense peptides, anti-cancer activity, cytotoxicity, therapy